Auto Added by WPeMatico
Google DeepMind and Isomorphic Labs outlined a bioresilience program to curb AI misuse in biology while aiding outbreak response. The two organisations published an update on a joint initiative that began quietly and has now built out more than 15 partnerships with government bodies, biosecurity organisations, and research groups over the past 12 months. The […]
Examining Google DeepMind’s AI bioresilience push Read More »
Nokia’s AI-RAN platform arrived on July 15 with a claim worth examining: that it is the industry’s first. The vendor says the platform, built on its anyRAN software and NVIDIA’s Aerial system, will let operators pull far more capacity from the spectrum they already own, and it has framed the launch as one of the most significant
Nokia’s AI-RAN platform: a radio comeback that runs on NVIDIA Read More »
AWS (Amazon Web Services) has explained how Bluesight developed Prism, an AI layer that connects hospital pharmacy and compliance data across its product suite. Prism Assistant for ControlCheck has reached general availability and operates across 20 health systems, according to AWS vendor statements. Meanwhile, a multi-product agent for 340B Group Purchasing Organisation (GPO) compliance remains
AWS and Bluesight build AI for hospital 340B compliance Read More »
A recent AWS GraphRAG deployment reduced drug research and development cycles in pharmaceutical environments by 87 percent. This acceleration is achieved by integrating previously separated proprietary databases into a unified and queryable knowledge graph. Historically, initial data gathering and screening phases took over six months per iteration, yielding a low five percent success rate. Crucial
AWS GraphRAG deployment cuts drug research cycles by 87% Read More »
Insilico Medicine is advancing to Phase III human trials for testing a drug identified by AI targeting idiopathic pulmonary fibrosis (IPF). This progression supplies the computational drug discovery sector with empirical test cases, advancing an AI medicine past early safety evaluations into late-stage efficacy validation. IPF destroys respiratory capacity through severe lung tissue scarring. Patients
Insilico Medicine advances AI drug for IPF to Phase III trials Read More »
Anthropic Claude Science now integrates the NVIDIA BioNeMo Agent Toolkit to accelerate computational life sciences research. Anthropic has launched the public beta of Claude Science, an AI workbench built for scientific research. The platform enables scientists to converse directly with digital agents using natural language to execute end-to-end research workflows. This system connects natively to
NVIDIA BioNeMo accelerates Anthropic Claude Science Read More »
Anthropic has launched Claude Sonnet 5 and restored access to its Fable and Mythos frontier models following a federal export control review. The decision marks the conclusion of an eighteen-day operational pause triggered by a US government export control directive on June 12, which forced the temporary suspension of Anthropic’s highest-capability systems. Government officials enacted
Anthropic deploys Claude Sonnet 5, Fable and Mythos restored Read More »
HP has scaled its OpenAI Frontier integration across global operations to optimise enterprise workflows and accelerate output. The hardware manufacturer initiated testing of the platform in February 2026. Early pilot programs yielded verified operational gains in software engineering and cybersecurity remediation. Expanding these initial trials into an enterprise-wide operating model requires connecting access protocols, contextual
HP accelerates enterprise workflows with OpenAI Frontier Read More »
SAP aligns fragmented commerce data structures to enable operational AI personalisation at the execution layer. Enterprise leadership routinely establishes objectives to anticipate customer requirements and deliver relevant interactions across digital touchpoints. However, the actual infrastructure running inside these enterprises fails to support systematic execution at the required volume. Recommendation engines display generic product listings because
Omio integrates OpenAI models across its engineering operations to accelerate travel product development and launch booking interfaces. The multimodal travel platform coordinates operations with over 3,000 transportation providers across 47 countries. Omio explicitly rejects the superficial addition of technology to outdated internal processes. The company’s CTO, Tomas Vocetka, requires all internal functions to completely redesign
Omio scales travel product development using OpenAI models Read More »
